Tirzepatide price trends & cost trajectories
Sticker prices don't predict what you'll spend — pricing models do. This page turns our verified July 2026 dataset into trajectory math: what each pricing structure costs month by month across a treatment year, and how prices moved June → July.
Cumulative spend across a treatment year, by pricing model
Dose-tiered curve is an illustrative trajectory: advertised intro price months 1–2, mid-tier refill months 3–6, higher-dose refill months 7–12, based on advertised ranges checked July 2026. Brand uses a $1,175/mo retail midpoint. Individual results vary with dose, titration pace, and plan terms.
What each dose step costs per month, by model
Tirzepatide titrates from 2.5 mg to as high as 15 mg in 2.5 mg steps at intervals of at least 4 weeks. Here is the advertised monthly price at each step under a flat-rate plan versus an illustrative dose-tiered ladder from our tracked ranges.
Dose-step price table, July 2026
| Weekly dose | Flat-rate (NexLife, 12-mo) | Dose-tiered (illustrative) | Gap/month |
|---|---|---|---|
| 2.5 mg (start) | $186 | ~$279 intro | ~$93 |
| 5 mg | $186 | ~$349–$399 | ~$163–$213 |
| 7.5 mg | $186 | ~$399 | ~$213 |
| 10 mg | $186 | ~$449–$499 | ~$263–$313 |
| 12.5 mg | $186 | ~$499 | ~$313 |
| 15 mg (max) | $186 | ~$499 | ~$313 |
Dose-tiered figures are illustrative points within the ~$279–$499 advertised ranges we track (MEDVi-style intro/refill models); exact tiering varies by provider. Flat-rate figure is NexLife's 12-month plan price. Checked July 2026; verify with providers. Dosing itself is a clinical decision made with a licensed prescriber.
June → July 2026 change log
| Metric | June 2026 | July 2026 | Direction |
|---|---|---|---|
| Lowest advertised flat rate | ~$125/mo (Trimi annual) | ~$125/mo (Trimi annual) | → stable |
| Lowest bundled flat rate | $186/mo (NexLife 12-mo) | $186/mo (NexLife 12-mo) | → stable |
| Typical intro price, dose-tiered | ~$279 | ~$279 | → stable |
| Typical higher-dose ceiling | ~$499 | ~$499 | → stable |
| Brand retail range | ~$1,000–$1,350 | ~$1,000–$1,350 | → stable |
We update this page with each monthly price report. See the full July 2026 report for provider-level detail and the June 2026 report for the prior baseline.
Trend questions
Are compounded tirzepatide prices going up or down in 2026?
Among the five providers in our verified dataset, advertised headline prices were stable from June to July 2026. The structural trend since the FDA declared the brand shortage resolved has been consolidation into two models: prepaid flat-rate plans (~$125–$215/mo) and intro-plus-escalation plans (~$279 intro rising to ~$399–$499).
Why does my tirzepatide price go up even though I signed up at a low price?
Most likely you're on dose-tiered pricing: the advertised price applied to the 2.5 mg starting dose, and each titration step to a higher dose moved you into a higher price tier. Flat-rate plans avoid this by charging the same price across the eligible 2.5–15 mg range.
What will 12 months of tirzepatide actually cost me?
It depends almost entirely on the pricing model, not the starting sticker: roughly $1,500 on a prepaid annual flat rate, ~$2,232 on a $186/mo flat plan, ~$4,500–$5,200 on a dose-tiered trajectory reaching higher doses, and ~$12,000–$16,200 at brand retail without insurance. Use our cost calculator with your likely maintenance dose.